GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Saniona AB (OSTO:SANION) » Definitions » EV-to-FCF

Saniona AB (OSTO:SANION) EV-to-FCF : -3.01 (As of May. 27, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Saniona AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Saniona AB's Enterprise Value is kr257.36 Mil. Saniona AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was kr-85.53 Mil. Therefore, Saniona AB's EV-to-FCF for today is -3.01.

The historical rank and industry rank for Saniona AB's EV-to-FCF or its related term are showing as below:

OSTO:SANION' s EV-to-FCF Range Over the Past 10 Years
Min: -236.08   Med: -9.79   Max: 274.92
Current: -3.01

During the past 12 years, the highest EV-to-FCF of Saniona AB was 274.92. The lowest was -236.08. And the median was -9.79.

OSTO:SANION's EV-to-FCF is ranked worse than
100% of 372 companies
in the Biotechnology industry
Industry Median: 8.36 vs OSTO:SANION: -3.01

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Saniona AB's stock price is kr1.95. Saniona AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was kr-1.278. Therefore, Saniona AB's PE Ratio for today is At Loss.


Saniona AB EV-to-FCF Historical Data

The historical data trend for Saniona AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Saniona AB EV-to-FCF Chart

Saniona AB Annual Data
Trend Jan14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.78 -4.23 -0.85 -0.57 -3.47

Saniona AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.57 -1.33 -4.74 -4.24 -3.47

Competitive Comparison of Saniona AB's EV-to-FCF

For the Biotechnology subindustry, Saniona AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Saniona AB's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Saniona AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Saniona AB's EV-to-FCF falls into.



Saniona AB EV-to-FCF Calculation

Saniona AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=257.362/-85.531
=-3.01

Saniona AB's current Enterprise Value is kr257.36 Mil.
Saniona AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-85.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Saniona AB  (OSTO:SANION) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Saniona AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.95/-1.278
=At Loss

Saniona AB's share price for today is kr1.95.
Saniona AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.278.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Saniona AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Saniona AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Saniona AB (OSTO:SANION) Business Description

Traded in Other Exchanges
Address
Smedeland 26B, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219.

Saniona AB (OSTO:SANION) Headlines

No Headlines